Adcock Ingram Holdings | AIP - 销售成本



销售成本 更改 日
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aspen Pharmacare ZAR 9.63B 3.1B 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Life Healthcare ZAR 9.38B 536M 2025-12
Moderna USD 452M 245M 2025-12
Netcare ZAR 6.89B 536M 2025-12
Organon & Co USD 745M 25M 2025-09
Revvity USD 350.4M 26.05M 2025-12
Viatris USD 2.56B 167.3M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12